Oxytocin enhances the expression of morphine-induced conditioned place preference in rats

Psychoneuroendocrinology

Volumn 53, Issue , 2015, Pages 159-169

  Moaddab, Mahsa ^a   Hyland, Brian I ^a   Brown, Colin H ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Addiction; Conditioned place preference; Morphine; Nucleus accumbens shell; Oxytocin; Reward

Indexed keywords

MORPHINE; OXYTOCIN; OXYTOCIN RECEPTOR; NARCOTIC ANALGESIC AGENT; OXYTOCIC AGENT; OXYTOCIN RECEPTOR, RAT;

ADULT; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSOCIATION; CONTROLLED STUDY; DRUG ABUSE; DRUG DETERMINATION; DRUG EFFECT; LOCOMOTION; MALE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PROTEIN EXPRESSION; RAT; REWARD; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN VENTRICLE; CONDITIONING; DRUG EFFECTS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; RANDOMIZATION; WISTAR RAT;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL VENTRICLES; CONDITIONING (PSYCHOLOGY); INJECTIONS, INTRAVENTRICULAR; MALE; MORPHINE; NUCLEUS ACCUMBENS; OXYTOCICS; OXYTOCIN; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, OXYTOCIN; REWARD;

EID: 84922831808     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2015.01.003     Document Type: Article

References (73)

1. Aguilar M.A., Rodriguez-Arias M., Minarro J. Neurobiological mechanisms of the reinstatement of drug-conditioned place preference. Brain Res. Rev. 2009, 59:253-277.
2. Averbeck B.B. Oxytocin and the salience of social cues. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:9033-9034.
3. Badiani A., Belin D., Epstein D., Calu D., Shaham Y. Opiate versus psychostimulant addiction: the differences do matter. Nat. Rev. Neurosci. 2011, 12:685-700.
4. Baracz S.J., Rourke P.I., Pardey M.C., Hunt G.E., McGregor I.S., Cornish J.L. Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behav. Brain Res. 2011, 228:185-193.
5. Benoussaidh A., Maurin Y., Rampin O. Possible neural mediation of the central effects of oxytocin on uterine motility. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R798-R804.
6. Benturquia N., Le Marec T., Scherrmann J.M., Noble F. Effects of nitrous oxide on dopamine release in the rat nucleus accumbens and expectation of reward. Neuroscience 2008, 155:341-344.
7. Bjorkstrand E., Eriksson M., Uvnas-Moberg K. Evidence of a peripheral and a central effect of oxytocin on pancreatic hormone release in rats. Neuroendocrinology 1996, 63:377-383.
8. Brown C.H., Bains J.S., Ludwig M., Stern J.E. Physiological regulation of magnocellular neurosecretory cell activity: integration of intrinsic, local and afferent mechanisms. J. Neuroendocrinol. 2013, 25:678-710.
9. Burkett J.P., Young L.J. The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl.) 2012, 224:1-26.
10. Caprioli D., Celentano M., Dubla A., Lucantonio F., Nencini P., Badiani A. Ambience and drug choice: cocaine- and heroin-taking as a function of environmental context in humans and rats. Biol. Psychiatry 2009, 65:893-899.
11. Carson D.S., Cornish J.L., Guastella A.J., Hunt G.E., McGregor I.S. Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology 2010, 58:38-43.
12. Celentano M., Caprioli D., Dipasquale P., Cardillo V., Nencini P., Gaetani S., Badiani A. Drug context differently regulates cocaine versus heroin self-administration and cocaine- versus heroin-induced Fos mRNA expression in the rat. Psychopharmacology (Berl.) 2009, 204:349-360.
13. Cheer J.F., Aragona B.J., Heien M.L., Seipel A.T., Carelli R.M., Wightman R.M. Coordinated accumbal dopamine release and neural activity drive goal-directed behavior. Neuron 2007, 54:237-244.
14. Compton W.M., Volkow N.D. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend. 2006, 81:103-107.
15. Cox B.M., Young A.B., See R.E., Reichel C.M. Sex differences in methamphetamine seeking in rats: impact of oxytocin. Psychoneuroendocrinology 2013, 38:2343-2353.
16. Cruz F.C., Babin K.R., Leao R.M., Goldart E.M., Bossert J.M., Shaham Y., Hope B.T. Role of nucleus accumbens shell neuronal ensembles in context-induced reinstatement of cocaine-seeking. J. Neurosci. 2014, 34:7437-7446.
17. de Leon-Casasola O.A. Opioid therapy in 2012: a call for a high degree of attention to detail. Introduction. J. Pain Symptom Manage. 2012, 44:S1-S3.
18. de Quervain D.J., Roozendaal B., McGaugh J.L. Stress and glucocorticoids impair retrieval of long-term spatial memory. Nature 1998, 394:787-790.
19. Dolen G., Darvishzadeh A., Huang K.W., Malenka R.C. Social reward requires coordinated activity of nucleus accumbens oxytocin and serotonin. Nature 2013, 501:179-184.
20. Evans S.L., Dal Monte O., Noble P., Averbeck B.B. Intranasal oxytocin effects on social cognition: a critique. Brain Res. 2014, 1580:69-77.
21. Ferguson D., Koo J.W., Feng J., Heller E., Rabkin J., Heshmati M., Renthal W., Neve R., Liu X., Shao N., Sartorelli V., Shen L., Nestler E.J. Essential role of SIRT1 signaling in the nucleus accumbens in cocaine and morphine action. J. Neurosci. 2013, 33:16088-16098.
22. Gil M., Bhatt R., Picotte K.B., Hull E.M. Oxytocin in the medial preoptic area facilitates male sexual behavior in the rat. Horm. Behav. 2011, 59:435-443.
23. Grace A.A., Floresco S.B., Goto Y., Lodge D.J. Regulation of firing of dopaminergic neurons and control of goal-directed behaviors. Trends Neurosci. 2007, 30:220-227.
24. Groppe S.E., Gossen A., Rademacher L., Hahn A., Westphal L., Grunder G., Spreckelmeyer K.N. Oxytocin influences processing of socially relevant cues in the ventral tegmental area of the human brain. Biol. Psychiatry 2013, 74:172-179.
25. Gu X.L., Yu L.C. Involvement of opioid receptors in oxytocin-induced antinociception in the nucleus accumbens of rats. J. Pain 2007, 8:85-90.
26. Han W.Y., Du P., Fu S.Y., Wang F., Song M., Wu C.F., Yang J.Y. Oxytocin via its receptor affects restraint stress-induced methamphetamine CPP reinstatement in mice: Involvement of the medial prefrontal cortex and dorsal hippocampus glutamatergic system. Pharmacol. Biochem. Behav. 2014, 119:80-87.
27. Harris G.C., Wimmer M., Randall-Thompson J.F., Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav. Brain Res. 2007, 183:43-51.
28. Hyman S.E., Malenka R.C., Nestler E.J. Neural mechanisms of addiction: the role of reward-related learning and memory. Annu. Rev. Neurosci. 2006, 29:565-598.
29. Karami M., Zarrindast M.R., Sepehri H., Sahraei H. Sulpiride injections into the medial septum reverse the influence of intra-medial septum injection of l-arginine on expression of place conditioning-induced by morphine in rats. Brain Res. 2003, 976:30-40.
30. Kita I., Yoshida Y., Nishino S. An activation of parvocellular oxytocinergic neurons in the paraventricular nucleus in oxytocin-induced yawning and penile erection. Neurosci. Res. 2006, 54:269-275.
31. Knobloch H.S., Charlet A., Hoffmann L.C., Eliava M., Khrulev S., Cetin A.H., Osten P., Schwarz M.K., Seeburg P.H., Stoop R., Grinevich V. Evoked axonal oxytocin release in the central amygdala attenuates fear response. Neuron 2012, 73:553-566.
32. Koo J.W., Mazei-Robison M.S., Chaudhury D., Juarez B., LaPlant Q., Ferguson D., Feng J., Sun H., Scobie K.N., Damez-Werno D., Crumiller M., Ohnishi Y.N., Ohnishi Y.H., Mouzon E., Dietz D.M., Lobo M.K., Neve R.L., Russo S.J., Han M.H., Nestler E.J. BDNF is a negative modulator of morphine action. Science 2012, 338:124-128.
33. Koob G.F., Volkow N.D. Neurocircuitry of addiction. Neuropsychopharmacology 2010, 35:217-238.
34. Kovacs C.L., Van Ree J.M. Behaviorally active oxytocin fragments simultaneously attenuate heroin self-administration and tolerance in rats. Life Sci. 1985, 37:1895-1900.
35. Kovacs G.L., Borthaiser Z., Telegdy G. Oxytocin reduces intravenous heroin self-administration in heroin-tolerant rats. Life Sci. 1985, 37:17-26.
36. Kovacs G.L., Faludi M., Telegdy G. Oxytocin diminishes heroin tolerance in mice. Psychopharmacology (Berl.) 1985, 86:377-379.
37. Kovacs G.L., Izbeki F., Horvath Z., Telegdy G. Effects of oxytocin and a derivative (Z-prolyl-d-leucine) on morphine tolerance/withdrawal are mediated by the limbic system. Behav. Brain Res. 1984, 14:1-8.
38. Kremarik P., Freund-Mercier M.J., Stoeckel M.E. Histoautoradiographic detection of oxytocin- and vasopressin-binding sites in the telencephalon of the rat. J. Comp. Neurol. 1993, 333:343-359.
39. Lintas A., Chi N., Lauzon N.M., Bishop S.F., Gholizadeh S., Sun N., Tan H., Laviolette S.R. Identification of a dopamine receptor-mediated opiate reward memory switch in the basolateral amygdala-nucleus accumbens circuit. J. Neurosci. 2011, 31:11172-11183.
40. Lobo M.K., Covington H.E., Chaudhury D., Friedman A.K., Sun H., Damez-Werno D., Dietz D.M., Zaman S., Koo J.W., Kennedy P.J., Mouzon E., Mogri M., Neve R.L., Deisseroth K., Han M.H., Nestler E.J. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010, 330:385-390.
41. Love T.M. Oxytocin, motivation and the role of dopamine. Pharmacol. Biochem. Behav. 2013, 119:49-60.
42. Manning M., Misicka A., Olma A., Bankowski K., Stoev S., Chini B., Durroux T., Mouillac B., Corbani M., Guillon G. Oxytocin and vasopressin agonists and antagonists as research tools and potential therapeutics. J. Neuroendocrinol. 2012, 24:609-628.
43. Manning M., Sawyer W.H. Discovery, development, and some uses of vasopressin and oxytocin antagonists. J. Lab. Clin. Med. 1989, 114:617-632.
44. McGregor I.S., Bowen M.T. Breaking the loop: oxytocin as a potential treatment for drug addiction. Horm. Behav. 2012, 61:331-339.
45. Melis M.R., Melis T., Cocco C., Succu S., Sanna F., Pillolla G., Boi A., Ferri G.L., Argiolas A. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats. Eur. J. Neurosci. 2007, 26:1026-1035.
46. Melis M.R., Succu S., Sanna F., Boi A., Argiolas A. Oxytocin injected into the ventral subiculum or the posteromedial cortical nucleus of the amygdala induces penile erection and increases extracellular dopamine levels in the nucleus accumbens of male rats. Eur. J. Neurosci. 2009, 30:1349-1357.
47. Moaddab M., Haghparast A., Hassanpour-Ezatti M. Effects of reversible inactivation of the ventral tegmental area on the acquisition and expression of morphine-induced conditioned place preference in the rat. Behav. Brain Res. 2009, 198:466-471.
48. Morales-Rivera A., Hernandez-Burgos M.M., Martinez-Rivera A., Perez-Colon J., Rivera R., Montalvo J., Rodriguez-Borrero E., Maldonado-Vlaar C.S. Anxiolytic effects of oxytocin in cue-induced cocaine seeking behavior in rats. Psychopharmacology (Berl.) 2014, 231:4145-4155.
49. Morgan M.M., Christie M.J. Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br. J. Pharmacol. 2011, 164:1322-1334.
50. Neumann I.D. Brain oxytocin: a key regulator of emotional and social behaviours in both females and males. J. Neuroendocrinol. 2008, 20:858-865.
51. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 2007, Elsevier Academic Press, London. sixth ed.
52. Phillips P.A., Abrahams J.M., Kelly J., Paxinos G., Grzonka Z., Mendelsohn F.A., Johnston C.I. Localization of vasopressin binding sites in rat brain by in vitro autoradiography using a radioiodinated V1 receptor antagonist. Neuroscience 1988, 27:749-761.
53. Qi J., Yang J.Y., Song M., Li Y., Wang F., Wu C.F. Inhibition by oxytocin of methamphetamine-induced hyperactivity related to dopamine turnover in the mesolimbic region in mice. Naunyn Schmiedebergs Arch. Pharmacol. 2008, 376:441-448.
54. Qi J., Yang J.Y., Wang F., Zhao Y.N., Song M., Wu C.F. Effects of oxytocin on methamphetamine-induced conditioned place preference and the possible role of glutamatergic neurotransmission in the medial prefrontal cortex of mice in reinstatement. Neuropharmacology 2009, 56:856-865.
55. Richardson K.A., Aston-Jones G. Lateral hypothalamic orexin/hypocretin neurons that project to ventral tegmental area are differentially activated with morphine preference. J. Neurosci. 2012, 32:3809-3817.
56. Robinson T.E., Kolb B. Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology 2004, 47(Suppl. 1):33-46.
57. Roohi N., Sarihi A., Shahidi S., Zarei M., Haghparast A. Microinjection of the mGluR5 antagonist MTEP into the nucleus accumbens attenuates the acquisition but not expression of morphine-induced conditioned place preference in rats. Pharmacol. Biochem. Behav. 2014, 126C:109-115.
58. Sanna F., Argiolas A., Melis M.R. Oxytocin-induced yawning: sites of action in the brain and interaction with mesolimbic/mesocortical and incertohypothalamic dopaminergic neurons in male rats. Horm. Behav. 2012, 62:505-514.
59. Shaham Y., Erb S., Stewart J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Brain Res. Rev. 2000, 33:13-33.
60. Sinha R., Li C.S. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev. 2007, 26:25-31.
61. Spiga S., Puddu M.C., Pisano M., Diana M. Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur. J. Neurosci. 2005, 22:2332-2340.
62. Stoop R. Neuromodulation by oxytocin and vasopressin. Neuron 2012, 76:142-159.
63. Sulzer D. How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 2011, 69:628-649.
64. Taylor S.E., Klein L.C., Lewis B.P., Gruenewald T.L., Gurung R.A., Updegraff J.A. Biobehavioral responses to stress in females: tend-and-befriend, not fight-or-flight. Psychol. Rev. 2000, 107:411-429.
65. van Ree J.M., de Wied D. Prolyl-leucyl-glycinamide (PLG) facilitates morphine dependence. Life Sci. 1976, 19:1331-1339.
66. Van Ree J.M., De Wied D. Modulation of heroin self-administration by neurohypophyseal principles. Eur. J. Pharmacol. 1977, 43:199-202.
67. Veinante P., Freund-Mercier M.J. Distribution of oxytocin- and vasopressin-binding sites in the rat extended amygdala: a histoautoradiographic study. J. Comp. Neurol. 1997, 383:305-325.
68. Waldherr M., Neumann I.D. Centrally released oxytocin mediates mating-induced anxiolysis in male rats. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:16681-16684.
69. Wang R., Zhang Y., Qing H., Liu M., Yang P. The extinction of morphine-induced conditioned place preference by histone deacetylase inhibition. Neurosci. Lett. 2010, 483:137-142.
70. Wang X.Y., Zhao M., Ghitza U.E., Li Y.Q., Lu L. Stress impairs reconsolidation of drug memory via glucocorticoid receptors in the basolateral amygdala. J. Neurosci. 2008, 28:5602-5610.
71. Witten I.B., Lin S.C., Brodsky M., Prakash R., Diester I., Anikeeva P., Gradinaru V., Ramakrishnan C., Deisseroth K. Cholinergic interneurons control local circuit activity and cocaine conditioning. Science 2010, 330:1677-1681.
72. Zanos P., Georgiou P., Wright S.R., Hourani S.M., Kitchen I., Winsky-Sommerer R., Bailey A. The oxytocin analogue carbetocin prevents emotional impairment and stress-induced reinstatement of opioid-seeking in morphine-abstinent mice. Neuropsychopharmacology 2014, 39:855-865.
73. Zhao L.Y., Zhang X.L., Shi J., Epstein D.H., Lu L. Psychosocial stress after reactivation of drug-related memory impairs later recall in abstinent heroin addicts. Psychopharmacology (Berl.) 2009, 203:599-608.